Line Lundegaard Bang, Lone Wulff Madsen, Rune Micha Pedersen, Anna Christine Nilsson, Isik Somuncu Johansen, Thomas Emil Andersen
{"title":"索托维单抗失去了对SARS-CoV-2亚变种的中和效力,但仍有临床疗效:针对 COVID-19 的单克隆抗体被过早拒绝了吗?","authors":"Line Lundegaard Bang, Lone Wulff Madsen, Rune Micha Pedersen, Anna Christine Nilsson, Isik Somuncu Johansen, Thomas Emil Andersen","doi":"10.1016/j.jiph.2024.102512","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 9","pages":"Article 102512"},"PeriodicalIF":4.7000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002466/pdfft?md5=14e2ca612233b0dbf71fb398383b26de&pid=1-s2.0-S1876034124002466-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?\",\"authors\":\"Line Lundegaard Bang, Lone Wulff Madsen, Rune Micha Pedersen, Anna Christine Nilsson, Isik Somuncu Johansen, Thomas Emil Andersen\",\"doi\":\"10.1016/j.jiph.2024.102512\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":16087,\"journal\":{\"name\":\"Journal of Infection and Public Health\",\"volume\":\"17 9\",\"pages\":\"Article 102512\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1876034124002466/pdfft?md5=14e2ca612233b0dbf71fb398383b26de&pid=1-s2.0-S1876034124002466-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1876034124002466\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034124002466","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.